Citations

Clear

153 citation(s) found for "Gleich, GJ".

Perioperative Cardiac Arrests in Children between 1988 and 2005 at a Tertiary Referral Center
Flick, Randall P., Harrison, Tracy E. , Gleich, Stephen J. , Schroeder, Darrell R. , Hanson, Andrew C. , Buenvenida, Shonie L., Warner, David O., Šprung, Juraj , Schroeder, Darrell

Mayo Clinic

Anesthesiology | January 22, 2007 | Volume: 106 | Issue: 2 | Pages: 226-237

10.1097/00000542-200702000-00009 | PMID 17264715 Get It

Background The objective of this study was to determine the incidence and outcome of perioperative cardiac arrest (CA) in children younger than 18 yr undergoing anesthesia for noncardiac and cardiac procedures at a tertiary care center. Methods After institutional review board approval (Mayo Clinic, Rochester, Minnesota), all patients younger than 18 yr who had perioperative CA between November 1, 1988, and June 30, 2005, were identified. Perioperative CA was defined as a need for cardiopulmonary resuscitation or death during anesthesia care. A cardiac procedure was defined as a surgical procedure involving the heart or great vessels requiring an incision. Results A total of 92,881 anesthetics were administered during the study period, of which 4,242 (5%) were for the repair of congenital heart malformations. The incidence of perioperative CA during noncardiac procedures was 2.9 per 10,000, and the incidence during cardiac procedures was 127 per 10,000. The incidence of perioperative CA attributable to anesthesia was 0.65 per 10,000 anesthetics, representing 7.5% of the 80 perioperative CAs. Both CA incidence and mortality were highest among neonates (0-30 days of life) undergoing cardiac procedures (incidence: 435 per 10,000; mortality: 389 per 10,000). Regardless of procedure type, most patients who experienced perioperative CA (88%) had congenital heart disease. Conclusion The majority of perioperative CAs were caused by factors not attributed to anesthesia, in distinction to some recent reports. The incidence of perioperative CA is many-fold higher in children undergoing cardiac procedures, suggesting that definition of case mix is necessary to accurately interpret epidemiologic studies of perioperative CA in children.
Measurement of IgE Protein and IgE Antibodies: The State of the Art
Gleich, Gerald J.

Mayo Clinic

Allergy and Asthma Proceedings | December 6, 2006 | Volume: 5 | Issue: 2 | Pages: 126-129

10.2500/108854184779063720 Get It

Characterization of "Peak E," a Novel Amino Acid Associated with Eosinophilia-Myalgia Syndrome
Mayeno, Arthur N., Foote, Christopher S., Loegering, David A., Ames, Matthew M. , Hedberg, Craig W. , Gleich, Gerald J. , Lin, Feng

Mayo Clinic

Science | October 5, 2006 | Volume: 250 | Issue: 4988 | Pages: 1707-1708

10.1126/science.2270484 | PMID 2270484 Get It

Epidemiologic studies strongly associate eosinophilia-myalgia syndrome (EMS) with ingestion of tryptophan containing a contaminant ("peak E"). Prior reports have suggested that peak E is the di-tryptophan Nα-animal of acetaldehyde. Spectral and chemical studies now demonstrate that peak E is 1,1′-ethylidenebis[tryptophan]. This novel amino acid may be the etiological agent responsible for EMS, or it may be a marker of a still unidentified causal agent.
Immunoglobulin E Antibodies to Pollen Allergens Account for High Percentages of Total Immunoglobulin E Protein
Gleich, Gerald J. , Jacob, G.L.

Mayo Clinic

Science | October 5, 2006 | Volume: 190 | Issue: 4219 | Pages: 1106-1108

10.1126/science.1188389 | PMID 1188389 Get It

The quantities of immunoglobulin E (IgE) antibodies to grass or ragweed allergens were measured by an immunoabsorption in the serums of patients sensitive to one of these allergens. IgE antibodies to grass or ragweed allergens accounted for means of 30 and 29 percent of the total IgE protein. After the ragweed pollination season, the levels of serum IgE antibodies to ragweed allergens rose dramatically and in postpollination serums they accounted for 39 percent of the total IgE protein with a range from 13 to 50 percent.
Antigen Combining Activity Associated with Immunoglobulin D
Gleich, Gerald J. , Bieger, R., Stankievic, Raisa

Mayo Clinic

Science | October 5, 2006 | Volume: 165 | Issue: 3893 | Pages: 606-606

10.1126/science.165.3893.606 | PMID 4183324 Get It

The titers of antibodies to the benzylpenicilloyl antigenic determinant are increased with specific antiserum to immunoglobulin D, as shown by the enhancement method. This increase in titer is blocked by purified immunoglobulin D protein but not by immunoglobulins of the other four classes.
Immunochemical Quantitation of an Airborne Proteolytic Enzyme, Esperase®, in a Consumer Products Factory
Agarwal, Monica , Ingram, Jordanm ., Dunnette, Sandra L., Gleich, G.J., Ingram, Jordan M.

Mayo Clinic

American Industrial Hygiene Association Journal | December 20, 2005 | Volume: 47 | Issue: 2 | Pages: 138-143

10.1080/15298668691389469 | PMID 3513509 Get It

Eosinophil-Associated Inflammation and Elaboration of Eosinophil-Derived Proteins in 2 Children With Raccoon Roundworm (Baylisascaris procyonis)Encephalitis
Kazacos, Kevin R., Butterfield, Joseph H. , Kita, Hirohito , Watterson, Jan, Gleich, Gerald J. , Moertel, Christopher L. , Kita, H

Mayo Clinic

Pediatrics | August 13, 2004 | Volume: 108 | Issue: 5 | Pages: e93-e93

10.1542/peds.108.5.e93 | PMID 11694677 Get It

Objective.Eosinophil-associated proteins, especially eosinophil-derived neurotoxin, may be important contributors to the neurologic pathology and symptoms caused byBaylisascaris procyonis infection.Methods.Two cases of severe B procyonisencephalitis with evidence of marked eosinophil degranulation in the central nervous system are presented. Serial cerebrospinal fluid (CSF) specimens were collected from each patient during the course of their illness. Antibodies against B procyonis were measured in the patients' serum and CSF. Levels of the eosinophilopoietin interleukin-5 (IL-5) and 2 important eosinophil proteins, eosinophil-derived neurotoxin and major basic protein, were assayed in the CSF.Results.Both patients had rapidly progressive central nervous system disease with evidence of eosinophilic meningoencephalitis. Both tested positive for antibodies to B procyonis in serum and CSF and had progressively worsening deep white matter changes on magnetic resonance images of the brain. CSF levels of IL-5, eosinophil-derived neurotoxin, and major basic protein were markedly elevated over controls.Conclusions.This is the first report of the measurement of IL-5, eosinophil-derived neurotoxin, and major basic protein in human CSF. In addition to traumatic damage and necrosis caused by migrating larvae, eosinophil-derived neurotoxin from associated eosinophilic inflammation may be an important contributory factor in the pathogenesis of B procyonis encephalitis. parasite, eosinophil-derived-neurotoxin, major basic protein, eosinophilia, hypereosinophilia, interleukin-5, encephalitis, child.
Chemokines active on eosinophils: potential roles in allergic inflammation.
Kita, Hirohito , Gleich, G J, Kita, H

Mayo Clinic

The Journal of experimental medicine | June 24, 2004 | Volume: 183 | Issue: 6 | Pages: 2421-2426

10.1084/jem.183.6.2421 | PMID 8676062 Get It

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils.
Ohnishi, Takeo, Okubo, Yoshio, Weiler, Deborah A., Abrams, J S, Gleich, G.J., Kita, Hirohito

Mayo Clinic

The Journal of experimental medicine | June 24, 2004 | Volume: 174 | Issue: 3 | Pages: 745-748

10.1084/jem.174.3.745 | PMID 1875171 Get It

Human peripheral blood eosinophils released eosinophil survival-enhancing activity when stimulated with the calcium ionophore, ionomycin. The release of activity was detected as early as 3 h after stimulation and was inhibited by an immunomodulating agent, cyclosporin A. The survival-enhancing activity was completely abolished by treatment with anti-interleukin 3 (IL-3) and anti-granulocyte/macrophage colony-stimulating factor (GM-CSF) monoclonal antibodies. Moreover, IL-3 and GM-CSF were measurable in ionomycin-stimulated eosinophil supernatants by immunoassay. Eosinophils produced approximately one-half as much IL-3 and one-fifth as much GM-CSF as ionomycin-stimulated mononuclear cells. Neutrophils also produced IL-3 and GM-CSF, but the amounts were less than those produced by eosinophils. These observations suggest a novel role for eosinophils in pathophysiology of allergic inflammation and host defense mechanisms.
Evidence of eosinophil granule major basic protein in human placenta.
Wasmoen, Terri, McKean, D J, Benirschke, Kurt, Coulam, Carolyn B. , Gleich, Gerald J.

Mayo Clinic

The Journal of experimental medicine | June 24, 2004 | Volume: 170 | Issue: 6 | Pages: 2051-2063

10.1084/jem.170.6.2051 | PMID 2584934 Get It

A protein immunochemically related to the eosinophil granule major basic protein (gMBP) is found in increased concentration in the plasma of pregnant women and has been localized to placental trophoblasts by immunofluorescence. Pregnancy MBP (pMBP) is indistinguishable from gMBP in its reactivity with polyclonal antisera and a panel of 14 mouse mAbs. We report the purification of pMBP from human placenta by: (a) affinity chromatography over mAb immobilized on Sepharose, (b) gel filtration in 6 M guanidine.HCl buffer, and (c) reversed-phase HPLC. Purified pMBP and gMBP are biochemically indistinguishable in that both: (a) bind to DNA, (b) polymerize and bind to carrier proteins via disulfide linkages, (c) have a molecular weight of 14,000, (d) have isoelectric points greater than 10.6, (e) comigrate in two-dimensional gels, (f) coelute during reversed-phase HPLC on C18 columns, (g) have identical peptide maps after three different digestions, and (h) have partial amino acid sequence identity. This physicochemical identity has important implications as to the role of pMBP in human placentation.